Medicamen Organics IPO Details
| IPO Size | 10.54 |
| Price Range | ₹32 - ₹34 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 4000 |
| Investment (cut-off price) | ₹136,000 |
| Pre IPO Promotor Holding | 81.21% |
| Post IPO Promotor Holding | -- |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Medicamen Organics IPO Timelines
21/06/2024
Start Date25/06/2024
End Date27/06/2024
Refund Initiation27/06/2024
Credit of Shares to Demat Ac28/06/2024
Listing DateMedicamen Organics IPO Lot Size
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 4000 | ₹136,000 |
| Retail Maximum | 1 | 4000 | ₹136,000 |
| S-HNI Minimum | 2 | 8000 | ₹272,000 |
Medicamen Organics IPO Subscription Status
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 1.42 x | 125.05 x | 339.69 x | -- | 197.39 x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹₹137.85 | ₹₹144.70 | ₹₹144.70 | ₹₹130.95 |
Medicamen Organics IPO Company Financials
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| Year 2021 | ₹25.06 | ₹24.57 | ₹0.30 |
| Year 2022 | ₹21.19 | ₹20.93 | ₹0.09 |
| Year 2023 | ₹22.96 | ₹21.60 | ₹0.96 |
| Year 2024 (9 M) | ₹11.33 | ₹9.57 | ₹1.29 |
About Company
Medicamen Organics Limited, incorporated in 1995 as Panchdeep Pharmaceuticals, is engaged in the manufacturing of pharmaceutical formulations and products, including tablets, capsules, oral liquids, and ointments. The company operates two WHO-GMP certified plants located in Haridwar. The product portfolio of Medicamen consists of 84 pharmaceutical products.
These belong to the anti-bacterial, anti diarrheal, anti-fungal, anti-diabetic, proton pump inhibitor, multi-vitamin, multi-mineral and non-steroidal anti-inflammatory drug (NSAIDS) categories. The company has an in-house testing facility and sources its raw materials from FDA-approved sources.
The company exports its products to countries on the African continent, CIS and SAARC countries. It is registered in 13 countries. The company’s products are marketed across India, Africa, Commonwealth of Independent States (CIS) and countries in south-east Asia by its third-party distributor.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 1995 | Healthcare | Bal Gupta |
Know Before Investing
Medicamen Organics IPO Strengths
- The company manufactures a wide range of products.
- Its business model is customer-centric and order-driven.
- It focuses on high quality and is certified.
- Experienced promoters and management team.
Medicamen Organics IPO Risks
- The company needs several approvals, licenses, registrations and permits to run the business.
- It is subject to risks associated with expansion into new markets.
- It is also subject to foreign currency exchange rate fluctuations.
- It has reported negative cash flow in the past.
- It operates in a competitive environment.
- High working capital requirements.
Swot Analysis for Medicamen Organics IPO
Strengths
Weaknesses
Opportunities
Threats
Contact Details of IXIGO
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
Company Details
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: [email protected]
Website: http://www.medicamenorganics.com/
IPO Registar Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
FAQs
- Funding of expenses proposed to be incurred towards Product registration in the international markets.
- Plant updation and increase in production capacity.
- Funding working capital requirements of our Company.